Skip to main content

United States Pediatric Medicines Market 2017 (Hospital, Children's Hospital and Pharmacy) Survey by Product Types, Segment, Company Pricing, Offers & Consumptions

Press Release   •   Aug 17, 2017 04:10 EDT

In this report, the United States Pediatric Medicines Market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Click Here To Get Request Sample: http://globalqyresearch.com/download-sample/256767 

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Pediatric Medicines in these regions, from 2012 to 2022 (forecast).

United States Pediatric Medicines market competition by top manufacturers/players, with Pediatric Medicines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
GSK
Sanofi
Bristol-Myers Squibb
Abbott
Novartis
Pfizer
Cipla
Eisai Pharmaceuticals
Eli Lilly
F. Hoffman-La Roche
Glenmark
Helsinn Healthcare
Heron Therapeutics
Ipca Laboratories
Sun Pharmaceutical Industries
Takeda Pharmaceutical
Lupin Pharmaceuticals
Merck Sharp & Dohme
RedHill

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
By Route of Administration
Enteral
Parenteral
Topical
By Form
Pills
Granules
Capsules

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Pediatric Medicines for each application, including
Hospital
Children's Hospital
Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

Ask Query Here:Jay@globalqyresearch.com or Sales@globalqyresearch.com

Table of Contents

United States Pediatric Medicines Market Report 2017
1 Pediatric Medicines Overview
1.1 Product Overview and Scope of Pediatric Medicines
1.2 Classification of Pediatric Medicines by Product Category
1.2.1 United States Pediatric Medicines Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Pediatric Medicines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Enteral
1.2.4 Parenteral
1.2.5 Topical
1.3 United States Pediatric Medicines Market by Application/End Users
1.3.1 United States Pediatric Medicines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Children's Hospital
1.3.4 Pharmacy
1.4 United States Pediatric Medicines Market by Region
1.4.1 United States Pediatric Medicines Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Pediatric Medicines Status and Prospect (2012-2022)
1.4.3 Southwest Pediatric Medicines Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Pediatric Medicines Status and Prospect (2012-2022)
1.4.5 New England Pediatric Medicines Status and Prospect (2012-2022)
1.4.6 The South Pediatric Medicines Status and Prospect (2012-2022)
1.4.7 The Midwest Pediatric Medicines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Pediatric Medicines (2012-2022)
1.5.1 United States Pediatric Medicines Sales and Growth Rate (2012-2022)
1.5.2 United States Pediatric Medicines Revenue and Growth Rate (2012-2022)

2 United States Pediatric Medicines Market Competition by Players/Suppliers
2.1 United States Pediatric Medicines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Pediatric Medicines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Pediatric Medicines Average Price by Players/Suppliers (2012-2017)
2.4 United States Pediatric Medicines Market Competitive Situation and Trends
2.4.1 United States Pediatric Medicines Market Concentration Rate
2.4.2 United States Pediatric Medicines Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Pediatric Medicines Manufacturing Base Distribution, Sales Area, Product Type

3 United States Pediatric Medicines Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Pediatric Medicines Sales and Market Share by Region (2012-2017)
3.2 United States Pediatric Medicines Revenue and Market Share by Region (2012-2017)
3.3 United States Pediatric Medicines Price by Region (2012-2017)

4 United States Pediatric Medicines Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Pediatric Medicines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Pediatric Medicines Revenue and Market Share by Type (2012-2017)
4.3 United States Pediatric Medicines Price by Type (2012-2017)
4.4 United States Pediatric Medicines Sales Growth Rate by Type (2012-2017)

5 United States Pediatric Medicines Sales (Volume) by Application (2012-2017)
5.1 United States Pediatric Medicines Sales and Market Share by Application (2012-2017)
5.2 United States Pediatric Medicines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Pediatric Medicines Players/Suppliers Profiles and Sales Data
6.1 GSK
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Pediatric Medicines Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GSK Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Sanofi
6.2.2 Pediatric Medicines Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Sanofi Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Bristol-Myers Squibb
6.3.2 Pediatric Medicines Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Bristol-Myers Squibb Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Abbott
6.4.2 Pediatric Medicines Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Abbott Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Novartis
6.5.2 Pediatric Medicines Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Novartis Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Pfizer
6.6.2 Pediatric Medicines Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Pfizer Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Cipla
6.7.2 Pediatric Medicines Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Cipla Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Eisai Pharmaceuticals
6.8.2 Pediatric Medicines Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Eisai Pharmaceuticals Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Eli Lilly
6.9.2 Pediatric Medicines Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Eli Lilly Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 F. Hoffman-La Roche
6.10.2 Pediatric Medicines Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 F. Hoffman-La Roche Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Glenmark
6.12 Helsinn Healthcare
6.13 Heron Therapeutics
6.14 Ipca Laboratories
6.15 Sun Pharmaceutical Industries
6.16 Takeda Pharmaceutical
6.17 Lupin Pharmaceuticals
6.18 Merck Sharp & Dohme
6.19 RedHill

7 Pediatric Medicines Manufacturing Cost Analysis
7.1 Pediatric Medicines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pediatric Medicines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Pediatric Medicines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pediatric Medicines Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Pediatric Medicines Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Pediatric Medicines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Pediatric Medicines Sales Volume Forecast by Type (2017-2022)
11.3 United States Pediatric Medicines Sales Volume Forecast by Application (2017-2022)
11.4 United States Pediatric Medicines Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer

To Purchase this Premium Report: http://globalqyresearch.com/checkout-form/0/256767

About Us:

Global QYResearch is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Browse Our Pharma Blog:http://pharmainvestmentnews.com/

Contact Us:

Unit1, 26 Cleveland Road, South Woodford, London, E182AN, United Kingdom

Contact: +44 20 3239 2407